As of July 14, 2026, Turn Therapeutics Inc. (TTRX) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Turn Therapeutics Inc. has a market capitalization of $154.90M, 29.79M shares outstanding, 20 institutional holders tracked. Key dilution vectors include 1.19M outstanding warrants, approximately 52 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TTRX.
💹 Market Data
Market Cap$154.90M
Shares Outstanding29.79M
Float11.13M
Cash$11.01M
Debt$5.94M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 11.9% shares (2026Q1 vs prior)
20 institutional holders · 521.8K shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
98.9K shares
#2
DDFG, Inc
70.5K shares
#3
MILLENNIUM MANAGEMENT LLC
69.8K shares
📉 Short Interest
Short Interest38.5K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for TTRX Shareholders
Turn Therapeutics Inc. (TTRX) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
DilutionWatch tracks 1.2M outstanding warrants for TTRX. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.
DilutionWatch tracks over 25 SEC filing types for TTRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for TTRX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track TTRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TTRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for TTRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.